The Transparency Directive

Over lunch, the background of the Directive (measures, scope), the reasons for its revision and the main modifications (introduction of provisions/procedures) were discussed.

The Q&A session focused on:

  • Obstacles in the decision-making process
  • Relationship between the Directive and Public procurement
  • Special character of Voluntary Contact Agreements – how the proposals would affect the way some countries organize their managed entry agreements.
  • TD with regards to regional and local formularies
  • Other initiatives that Ms Nistor is responsible for

Speaker: Laura Nistor,  Policy Officer – Pharmaceuticals, Food and Healthcare Industries, Biotechnology, DG ENTR

24 April 2012, Alessio

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: